| 000 | 01365 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514021433.0 | ||
| 264 | 0 | _c20020730 | |
| 008 | 200207s 0 0 eng d | ||
| 022 | _a1027-3719 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGupta, R | |
| 245 | 0 | 0 |
_aShould tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)? _h[electronic resource] |
| 260 |
_bThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _cDec 2001 |
||
| 300 |
_a1078-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntitubercular Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aGovernment Programs _xtrends |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInternational Cooperation |
| 650 | 0 | 4 |
_aIsoniazid _xtherapeutic use |
| 650 | 0 | 4 |
_aNational Health Programs _xtrends |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aRifampin _xtherapeutic use |
| 650 | 0 | 4 |
_aTuberculosis, Multidrug-Resistant _xdrug therapy |
| 650 | 0 | 4 | _aWorld Health Organization |
| 700 | 1 | _aRaviglione, M C | |
| 700 | 1 | _aEspinal, M A | |
| 773 | 0 |
_tThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _gvol. 5 _gno. 12 _gp. 1078-9 |
|
| 999 |
_c11681843 _d11681843 |
||